Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
7.2M
-
Shares change
-
-569K
-
Total reported value, excl. options
-
$56.7M
-
Value change
-
-$4.24M
-
Number of buys
-
11
-
Number of sells
-
-15
-
Price
-
$7.88
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2017
40 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q4 2017.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.2M shares
of 71.9M outstanding shares and own 10.01% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.69M shares), Neumann Advisory Hong Kong Ltd (403K shares), GLG Partners LP (271K shares), DEUTSCHE BANK AG\ (245K shares), Eqis Capital Management, Inc. (156K shares), STATE STREET CORP (88.3K shares), WELLINGTON MANAGEMENT GROUP LLP (69.1K shares), Spark Investment Management LLC (66.1K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (62K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.